Array BioPharma
| Type | Subsidiary of Pfizer |
|---|---|
| Industry | Oncology Medication |
| Founded | 1998 |
| Founder | Drs. Tony Piscopio, Kevin Koch, David Snitman, and K.C. Nicolaou |
| Headquarters | , United States of America |
| Revenue | $173.8 million (2018) |
| Parent | Pfizer |
| Website | www |
Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is a subsidiary of Pfizer.
History[]
In 1998, the company was founded by Drs. Tony Piscopio, Kevin Koch, David Snitman, and K.C. Nicolaou.[1]
In November 2000, the company became a public company via an initial public offering.[2]
In June 2019, Pfizer acquired the company for approximately $11 billion.[3]
References[]
- ^ "Co-Founder Of Array BioPharma, Inc. To Lead New Korean Out-Sourcing Chemistry Company". BioSpace. Retrieved 2020-07-28.
- ^ "Array IPO up 17%". CNN. November 17, 2000.
- ^ "Pfizer acquires Array BioPharma, valued at $11.4 billion". Rappler. Retrieved 2020-07-29.
Authority control  |
|
|---|
Categories:
- 1998 establishments in Colorado
- 2000 initial public offerings
- 2019 mergers and acquisitions
- American companies established in 1998
- Pharmaceutical companies established in 1998
- Biotechnology companies established in 1998
- Pharmaceutical companies of the United States
- Companies formerly listed on the Nasdaq
- Biotechnology companies of the United States
- Health care companies based in Colorado
- Companies based in Boulder, Colorado
- Pfizer
- Biopharmaceutical companies